Back
Qure.ai today announced the promotion of Amy Casey, a former Microsoft and Nuance leader, to Executive Vice President of Sales for North America and the appointment of Malika Shrivastava, a former Google executive, as its first Chief Marketing Officer, strengthening its leadership team as the company scales its commercial operations to meet growing demand for healthcare AI in the United States.
The appointments reflect Qure.ai's continued investment in scaling its US business and strengthening the commercial capabilities needed to support growing demand for AI-powered healthcare solutions. With FDA clearances spanning 26 findings and a growing footprint in the United States, the company is expanding its leadership team as healthcare organizations increasingly adopt AI to improve clinical workflows, enable earlier diagnosis and address capacity constraints.
"Healthcare is entering a defining era where AI will fundamentally reshape how care is delivered, improving outcomes while addressing longstanding gaps in access and efficiency," said Prashant Warier, CEO and Co-founder of Qure.ai. "The United States represents one of our most important growth markets, and we are making deliberate investments in leadership to support our next phase of expansion. Amy brings extensive experience leading enterprise software sales across the US healthcare ecosystem, while Malika brings a proven track record of building brands and scaling businesses globally, including in the US market.”
As Executive Vice President of Sales for North America, Casey, who joined Qure.ai a year ago, will lead Qure.ai's commercial strategy and customer engagement across the region. Casey has played a key role in expanding Qure.ai's presence in the United States and brings more than two decades of experience leading enterprise software sales, strategic account management and commercial growth across the US healthcare market. Prior to joining Qure.ai, she spent 16 years across Microsoft and Nuance, leading national accounts and helping health systems modernize clinical and operational workflows through technology adoption.
"Qure.ai is at the forefront of applying AI to solve some of healthcare's most pressing challenges, from early disease detection to population health management," said Casey. "I am excited to lead Qure.ai's US operations as the company delivers meaningful clinical impact at scale, and I look forward to partnering with health systems and healthcare organizations across North America to accelerate the adoption of AI solutions that deliver meaningful clinical and operational outcomes."
As Qure.ai's inaugural Chief Marketing Officer, Shrivastava will lead the company's global marketing organization, overseeing brand, communications, product marketing, and market development. She brings over 15 years of experience building and scaling iconic brands, launching new products, driving go-to-market strategy, and expanding businesses across markets and stages of growth. Prior to joining Qure.ai, she led growth and go-to-market strategy at Glance (InMobi Group), where she scaled the India business and spearheaded expansion into the United States. Earlier, she held marketing leadership roles at Google, shaping growth for products including Android, Play, Chrome, and Pixel, and at Procter & Gamble, where she managed leading brands such as Always (Whisper) and Pampers across India and Southeast Asia.
Commenting on her appointment, Shrivastava said, "Qure.ai represents a rare combination of technological innovation, meaningful real-world impact, and a deeply mission-driven culture. As healthcare systems around the world increasingly adopt AI to improve access, quality, and efficiency of care, Qure is uniquely positioned to lead this transformation. I am excited to build on the strong foundation created by the team and help make Qure a brand that is not only recognized for its innovation, but deeply loved, trusted and respected by healthcare providers, partners, policymakers, and future talent globally."
Qure.ai's AI solutions are deployed in more than 105 countries and have impacted over 45 million lives worldwide. In the United States, the company continues to expand its footprint and build strategic relationships across the healthcare ecosystem, supporting providers and industry partners in adopting AI at scale.
